Form 8-K - Current report:
SEC Accession No. 0001213900-24-047146
Filing Date
2024-05-28
Accepted
2024-05-28 17:19:04
Documents
14
Period of Report
2024-05-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0206977-8k_lucy.htm   iXBRL 8-K 35942
2 PRESS RELEASE OF LUCY SCIENTIFIC DISCOVERY, INC., DATED MAY 28, 2024 ea020697701ex99-1_lucy.htm EX-99.1 7438
  Complete submission text file 0001213900-24-047146.txt   220407

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lsdi-20240521.xsd EX-101.SCH 3033
4 XBRL LABEL FILE lsdi-20240521_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE lsdi-20240521_pre.xml EX-101.PRE 22371
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0206977-8k_lucy_htm.xml XML 3684
Mailing Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6
Business Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6 778-410-5195
Lucy Scientific Discovery, Inc. (Filer) CIK: 0001865127 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41616 | Film No.: 24993063
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)